Sep 10 |
Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
|
Aug 21 |
Silo Pharma files for secondary stock offering
|
Aug 14 |
Silo Pharma Expands Development Agreement with Sever Pharma for Novel Ketamine Implant Therapeutic
|
Aug 7 |
Silo Pharma announces partnership with global CRO for central nervous system homing peptide
|
Aug 7 |
Silo Pharma Announces Partnership with Global CRO for Central Nervous System Homing Peptide
|
Jul 26 |
Silo Pharma to Present at H.C. Wainwright Annual Global Investment Conference
|
Jul 22 |
Silo Pharma Announces Closing of $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
Jul 19 |
Silo Pharma stock plummets on $2.1M registered direct offering priced ATM
|
Jul 19 |
Silo Pharma Announces $2.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
|
Jul 18 |
US Stocks Edge Higher; D.R. Horton Posts Upbeat Earnings
|